Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.

ABSTRACT: Understanding the pathophysiology of SARS-CoV-2 infection is critical for therapeutic and public health strategies. Viral-host interactions can guide discovery of disease regulators, and protein structure function analysis points to several immune pathways, including complement and coagulation, as targets of coronaviruses. To determine whether conditions associated with dysregulated complement or coagulation systems impact disease, we performed a retrospective observational study and found that history of macular degeneration (a proxy for complement-activation disorders) and history of coagulation disorders (thrombocytopenia, thrombosis and hemorrhage) are risk factors for SARS-CoV-2-associated morbidity and mortality-effects that are independent of age, sex or history of smoking. Transcri

SUBMITTER: Ramlall V 

PROVIDER: S-EPMC7809634 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature